2022 the Japanese Society of Medical Oncology Annual Meeting

Session information

Poster Session

[P54] Poster Session 54 Translational Research/Clinical Pharmacology(Miscellaneous)

Aoi Okamoto1, Yohei Funakoshi2, Masahiro Oe3, Ryo Takai4, Hirotaka Suto2, Yoshiaki Nagatani2, Meiko Nishimura2, Yoshinori Imamura2, Naomi Kiyota2,5, Koji Miki3, Kouichi Ohe3, Hirokazu Tanino1, Hironobu Minami2,5 (1.Division of Breast and Endocrine Surgery, Department of Surgery, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan, 2.Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan, 3.Department of Energy and Hydrocarbon Chemistry, Graduate School of Engineering, Kyoto University, Kyoto, Japan, 4.Division of Gastrointestinal Surgery, Department of Surgery, Kobe University Hospital and Graduate School of Medicine, Kobe, Japan, 5.Cancer Center, Kobe University Hospital, Kobe, Japan)

Kenji Tsuchihashi1,2, Juntaro Yamazaki2, Kentaro Suina2, Eishi Baba3, Koichi Akashi1, Hideyuki Saya2, Osamu Nagano2 (1.Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, 2.Division of Gene Regulation, Institute for Advanced Medical Research, Keio University School of Medicine, 3.Department of Oncology and Social Medicine, Graduate School of Medical Sciences, Kyushu University)

Hisano Yanagi1, Takashi Watanabe2, Atsushi Enomoto3, Oltea Sampetrean4, Hideyuki Saya4, Yohei Shimono2, Kenji Kawada1 (1.Department of Medical Oncology, Fujita Health University School of Medicine, 2.Department of Biochemistry, Fujita Health University School of Medicine, 3.Department of Pathology, Nagoya University Graduate School of Medicine, 4.Division of Gene Regulation, Institute for Advanced Medical Research, Graduate School of Medicine, Keio University)

Tomoyasu Yoshihiro1, Hiroshi Ariyama1, Kenji Tsuchihashi1, Taichi Isobe2, Hitoshi Kusaba1, Koichi Akashi1, Eishi Baba2 (1.Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, 2.Department of Oncology and Social Medicine, Kyushu University Graduate School of Medical Sciences)

Jason Yongsheng Chan1, Dave Yong Xiang Ng2, Zhimei Li2, Elizabeth Lee2, Jessica Sook Ting Kok2, Jing Yi Lee2, Joanna Koh2, Cedric Chuan-Young Ng2, Abner Herbert Lim2, Wei Liu2, Sheng Rong Ng2, Kah Suan Lim2, Xi Xiao Huang2, Jing Han Hong2, Peiyong Guan2, Yirong Sim3, Aye Aye Thike4, Nur Diyana Md Nasir4, Puay Hoon Tan4, Bin Tean Teh2 (1.Division of Medical Oncology, National Cancer Centre Singapore, 2.Laboratory of Cancer Epigenome, National Cancer Centre Singapore, 3.Division of Surgical Oncology, National Cancer Centre Singapore, 4.Division of Pathology, Singapore General Hospital)

Bayarbat Tsevegjav1,2, Atsushi Takano1,2,3, Ming Zhu1,2, Yoshihiro Yoshitake4, Masanori Shinohara4, Yataro Daigo1,2,3 (1.Department of Medical Oncology, Shiga University of Medical Science, 2.Ctr. for Advanced Med. against Cancer, Shiga Univ. of Med. Sci., 3.Ctr. for Antibody and Vaccine Ther, Inst. Med. Sci., Univ. of Tokyo, 4.Dept. of Oral and Maxillofacial Surg. Kumamoto Univ.)

Regina Mbugua1,2, Atsushi Takano1,2,3, Bayarbat Tsevegjav1,2, Yohei Miyagi4, Yataro Daigo1,2,3 (1.Shiga University of Medical Science, Dept. of Medical Oncology, 2.Ctr. Advanced Med. against Cancer, Shiga Univ. of Med. Sci., Otsu, Shiga, Japan, 3.Ctr. Antibody and Vaccine Therapy, Inst. Med. Sci., Univ. Tokyo, Tokyo, Japan, 4.Mol. Pathology & Genet. Div., Kanagawa Cancer Ctr., Kanagawa, Japan)

Ming Zhu1,2, Atsushi Takano1,2,3, Bayarbat Tsevegjav1,2, Yoshihiro Yoshitake4, Masanori Shinohara4, Yataro Daigo1,2,3 (1.Dep. of Med. Oncol. & Cancer Ctr., Shiga Univ. Med. Sci., 2.Ctr. for Advanced Med. against Cancer, Shiga Univ. of Med. Sci., 3.Ctr. for Antibody and Vaccine Ther, Inst. Med. Sci., Univ. of Tokyo, 4.Dept. of Oral and Maxillofacial Surg. Kumamoto Univ.)